Production (Stage)
Assembly Biosciences, Inc.
ASMB
$13.52
-$0.04-0.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 28.03% | 7.48% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 28.03% | 7.48% | |||
| Cost of Revenue | 4.00% | 5.66% | |||
| Gross Profit | 21.54% | -3.79% | |||
| SG&A Expenses | -2.17% | 7.54% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.49% | 6.11% | |||
| Operating Income | 13.80% | -5.26% | |||
| Income Before Tax | 15.30% | -8.30% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 14.68% | -7.51% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 14.68% | -7.51% | |||
| EBIT | 13.80% | -5.26% | |||
| EBITDA | 13.84% | -5.28% | |||
| EPS Basic | 25.72% | -4.49% | |||
| Normalized Basic EPS | 26.26% | -5.26% | |||
| EPS Diluted | 25.72% | -4.49% | |||
| Normalized Diluted EPS | 26.26% | -5.26% | |||
| Average Basic Shares Outstanding | 14.86% | 2.89% | |||
| Average Diluted Shares Outstanding | 14.86% | 2.89% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||